Canada: Fragile economy under trade and energy strain – Rabobank
Rabobank describes Canada’s economy as fragile, with back-to-back quarterly contractions marking a technical recession and weak investment and trade dragging growth. Elevated gasoline prices risk demand destruction, while US tariffs and USMCA uncertainty weigh on business and consumer confidence, limiting the effectiveness of Bank of Canada policy in countering externally driven shocks.
Technical recession and weak investment
"Elevated gasoline prices means that the risk of demand destruction due to present inflation is high. This puts Canada in an especially precarious position given the recent GDP print, which registered contraction at -0.1% quarterly annualized."
"Poor investment has dragged down growth and there aren’t promising signs at this juncture to suggest that we’re seeing a dramatic turnaround in Q2. Meanwhile, the trade balance also supressed growth, as exports contracted by -0.5% and imports increased from 2% in Q4 of last year to 12% in Q1—the greatest increase since 2022."
"The Q1 print is concerning as it came after a contractionary print of -1.0% in the previous quarter—marking a technical recession. Several Canadian policymakers have brushed off this most recent activity print, with Mark Carney saying that the Canadian government has “been in the process of laying the foundations for a stronger, more resilient, more independent Canadian economy."
"We continue to expect the Canadian economy to grow modestly as it adjusts to US tariffs and trade policy uncertainty, but recent data suggest that near-term economic growth will be weaker than anticipated in January."
"The Bank’s April forecast projects GDP growth of 1.2% in 2026, rising to 1.6% in 2027 and 1.7% in 2028 as growth in exports and business investment resumes along a lower trajectory."
(This article was created with the help of an Artificial Intelligence tool and reviewed by an editor.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SUI SuperTrend Flips to Buy — Macro Shift From Bearish to Bullish Begins

Novo Nordisk (NVO.US) unveils $23 billion pipeline blueprint, but the market isn't buying it! Investors ask, "How to turn the tide against adversity?"
After being surpassed by Eli Lilly in the obesity market, Novo Nordisk failed to present a concrete turnaround plan to CEO Mike Doustdal, disappointing investors. The company has pledged to launch more than five blockbuster drugs in the coming years and achieve over $23 billion in new sales, but the press conference lacked details on how to drive growth.

STONK hits new highs after erasing 27% crash

25 Days, Four Launches in Sight! Rocket Lab (RKLB.US) Accelerates Rocket Launches to Advance Its Ambitious "Space AI Infrastructure" Goals
After another successful mission, Rocket Lab's 97th Electron rocket is now positioned at the launch pad. This flight will be Rocket Lab's fourth launch in 25 days and its 18th launch in 2026.
